ASCO 2022 Conference Coverage


 

Lecture Summary - ASCO 2022 Bosutinib in Newly Diagnosed CML: Gastrointestinal, Liver, Effusion, and Renal Safety Characterization in the BFORE Trial

6 views
June 15, 2022
0 Comments
Login to view comments. Click here to Login
Leukemia